Related Experiment Video
Updated: Jul 11, 2026

10:11
Whole-Body Nanoparticle Aerosol Inhalation Exposures
Published on: May 7, 2013
16.4K
Development of risk-based nanomaterial groups for occupational exposure control.
E D Kuempel1, V Castranova2, C L Geraci3
1Education and Information Division, Nanotechnology Research Center (NTRC), National Institute for Occupational Safety and Health (NIOSH), Cincinnati, OH, USA.
Summary
Developing hazard categories for nanomaterials is essential for workplace safety. This approach uses benchmark materials to assess risks and guide exposure controls for diverse nanoparticles.
Area of Science:
- Occupational Health and Safety
- Nanotoxicology
- Risk Assessment
Background:
- The vast diversity of nanomaterials makes individual hazard assessment impractical.
- Standardized methods are needed for occupational health hazard evaluation of nanomaterials.
- Existing risk assessment strategies require adaptation for novel materials.
Purpose of the Study:
- To propose a strategy for categorizing nanomaterials based on hazard and risk.
- To facilitate the development of effective workplace exposure control practices.
- To illustrate quantitative risk assessment using benchmark materials.
Main Methods:
- Selecting representative benchmark nanomaterials from different mode of action (MOA) classes.
- Evaluating hazards and developing risk estimates for benchmark materials.
- Comparing new nanomaterials to benchmarks within the same MOA class for risk assessment.
Main Results:
- Poorly soluble particles were used as an example for quantitative risk assessment.
- Linking benchmark particles to exposure control bands aids practical application.
- Categorization relies on science-based analysis and default assumptions when data is limited.
Conclusions:
- A benchmark material strategy can enable hazard and risk categorization for nanomaterials.
- This approach supports informed decision-making for workplace exposure controls.
- Further research is needed to obtain sufficient dose-response data for robust categorization.
Related Concept Videos
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

